Science hype deserves negative attention for the harm it does including both to science itself and to patients. I’ve seen two really egregious examples of hype lately in science headlines. First from the Washington Post comes a stem cell story with a very hype-ful title: Stanford researchers ‘stunned’ by stem cell experiment that helped stroke […]
2 Recent Science Hype Awards on CRISPR & Stem Cells Read More »
Campaigns are underway in several European countries against the possible use of genetic modification in humans to make designer babies and one has a distinctly anti-CRISPR tone. For example, in France a group is pushing an anti-GM baby campaign and the same kind of thing is going on in Switzerland, which I blogged about recently. In
First anti-CRISPR political campaign is born in Europe Read More »
Michael Zerbe spoke at our CRISPR ethics symposium here at UC Davis this past week and made some interesting points. For more on his talk and the panel he was part of, see this post. His most provocative argument was for a warning label on CRISPR papers (see above). I know it’s slightly fuzzy, but
Does CRISPR need a warning label? asks Michael Zerbe Read More »
Here is another of my blog posts from yesterday’s CRISPR meeting on ethics, science, and policy held here at UC Davis. You can read the others here, here, and here. Note as with the other posts, since I was taking notes as listening and on the fly, this post is a stream of consciousness on
UC Davis CRISPR meeting: Vital Role of Language in CRISPR Read More »
The second session at our CRISPR meeting was really powerful. As with other posts from the UC Davis CRISPR meeting, since I was taking notes on the fly during this session, this post is a stream of bits from the different talks, often trying to capture the essence of key questions or ideas as the speakers
UC Davis CRISPR Meeting Panel: A View from the Trenches on Human Disease Read More »
The CRISPR meeting has started off wonderfully with a talk by Ben Hurlbut. His talk was entitled, “The Demands of CRISPR’s World: Imagination, Deliberation and Governance”. Since I took notes and listened this post is somewhat freeform. I liked how Ben asked a lot of questions. What is “CRISPR’s world” as Science Magazine called it? How
UC Davis CRISPR Meeting: Big Picture from Ben Hurlbut Read More »
There’s a great meeting going on today here at UC Davis starting soon on CRISPR, focused on the intersection of the science with bioethical and legal issues. I’ve been helping to organize this meeting, but kudos and thanks go to my colleague Mark Yarborough who took the lead in organizing the meeting and did most
Blogging UC Davis CRISPR Science & Bioethics Meeting Read More »
The gene editing technology CRISPR has been arguably the top story in the biomedical world in the last two years, but going forward there is a CRISPR challenger in upstart gene editing technology NgAgo. For more background on NgAgo and the key first published paper on its genetic modification characteristics see my post here. In the comments on that
NgAgo a-go-go: main bullet points on upstart CRISPR challenger Read More »
Some stuff on my mind for our TGIF Science this week. Research Funding Ups: NIH. Is it my imagination or is NIH funding slightly improving? This is the overall vibe I’m hearing from the trenches. Research Funding Ups and Downs: CIRM. CIRM funded some basic research to the tune of a total of $4 million,
TGIF Science: funding, CRISPR v. NgAgo, secrets, Zika, & more Read More »
2020 Update: early NgAgo reports have been mostly discredited and there is doubt on its function as a gene-editing method. What could be better than CRISPR for gene editing? A new genetic modification technology called NgAgo has some researchers really excited. How does it compare to CRISPR? I’ll admit it that as a scientist who works on
Will new gene editing tech NgAgo challenge CRISPR? Read More »